Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

MGTX

MeiraGTx Holdings plc

Healthcare · Biotech

$11.11Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

MeiraGTx Holdings plc shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +8611% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +8611% YoY in Q2 FY2026

Pipeline evidence · 0d ago

MGTX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on MGTX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full MGTX earnings analysis

Reported figures for MeiraGTx Holdings plc — research only, not investment advice.

Revenue YoY
+8610.8%

Latest Intelligence

Updated

What happened recently for MeiraGTx Holdings plc (MGTX) — events, not interpretation.

Event
Reported Q2 2026 revenue +8611% YoY.
Also
Last session September 28, 2026 at $11.11.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

MeiraGTx Holdings plc (MGTX)

Healthcare · Biotech

Investment Snapshot above is the primary AlphaOS analysis for MeiraGTx Holdings plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotech
Market cap:
$1.07B
Revenue:
$81.39M

MGTX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow MeiraGTx Holdings plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.